Targeting autophagy as a therapeutic strategy against pancreatic cancer.

Authors:
Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K and 1 more

Journal:
J Gastroenterol

Publication Year: 2022

DOI:
10.1007/s00535-022-01889-1

PMCID:
PMC9392712

PMID:
35727403

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of p…
Kashiro A; Kobayashi M; Oh T and 23 more (2024) - Transparency Score: 3/6
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis.
Leech T; Peiris M. (2024) - Transparency Score: 3/6
Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan…
Sasaki K; Kawai K; Nozawa H and 17 more (2024) - Transparency Score: 4/6
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19…
Nakase H; Wagatsuma K; Nojima M and 31 more (2023) - Transparency Score: 4/6
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating…
Jiang K; Lu S; Li D and 7 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestAll authors declare that they have no conflicts of interest. Conflict of interest All authors declare that they have no conflicts of interest."

Evidence found in paper:

"K.Y. was supported by the Yasuda Medical Foundation, Tokyo Society of Medical Sciences, MSD Life Science Foundation, Astellas Foundation for Research on Metabolic Disorders, Uehara Memorial Foundation, Princess Takamatsu Cancer Research Fund, Life Science Foundation of Japan, and JSPS KAKENHI (Grant numbers 21K20828, 22H02898, and 22H03053)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025